More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$5.71B
EPS
-0.17
P/E ratio
--
Price to sales
3.09
Dividend yield
--
Beta
1.484261
Previous close
$78.66
Today's open
$78.93
Day's range
$73.82 - $79.67
52 week range
$45.00 - $85.84
show more
CEO
Howard G. Berger
Employees
11021
Headquarters
Los Angeles, CA
Exchange
NASDAQ Global Market
Shares outstanding
77282458
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow
Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, 1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced today the launch of the DeepHealth Breast Suite, 2 a first-of-its-kind end-to-end suite of modular, interoperable AI-powered applications that address real-world clinical needs across the breast cancer screening and detection pathways. Breast Suite builds on organic innovation and integrated technologies from iCAD to deliver a comprehensive new suite of solutions.
GlobeNewsWire • Dec 1, 2025

DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions. The company is announcing new offerings and major enhancements across its portfolio, spanning disease detection, assessment and monitoring, remote scanning, image management and interpretation, center operations and AI orchestration—all designed to transform the imaging experience and advance population health.
GlobeNewsWire • Nov 30, 2025

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth's Novel AI-Powered Breast Cancer Detection Workflow
Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations
GlobeNewsWire • Nov 17, 2025

GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities
GlobeNewsWire • Nov 12, 2025

RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening
Acquisition supplements CIMAR's cloud-native infrastructure with DeepHealth's AI-powered informatics to deliver connected, efficient and accessible care
GlobeNewsWire • Nov 11, 2025

RadNet, Inc. (RDNT) Q3 2025 Earnings Call Transcript
RadNet, Inc. ( RDNT ) Q3 2025 Earnings Call November 10, 2025 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Brian Tanquilut - Jefferies LLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the RadNet Inc. Third Quarter 2025 Financial Results Conference Call.
Seeking Alpha • Nov 10, 2025

RadNet (RDNT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research • Nov 10, 2025

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges
LOS ANGELES, Nov. 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, today reported financial results for its third quarter of 2025.
GlobeNewsWire • Nov 9, 2025

Exploring Analyst Estimates for RadNet (RDNT) Q3 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Zacks Investment Research • Nov 6, 2025

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT's Assets
DeepHealth commercializes remote-imaging offering featuring TechLive™ remote scanning and Alpha RT's MRI staffing services, training and safety software.
GlobeNewsWire • Nov 5, 2025

¹ Disclosures

Open an M1 investment account to buy and sell RadNet Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.